August Group Capital Ltd

Position in LLY — ELI LILLY & Co

CIK 2107394 Toronto, A6

Position in LLY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$985,931

+$201,368 QoQ

Shares Held

822

-3.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.70%

of 13F equity value

Holder Rank

#3,158

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

August Group Capital Ltd holds $3,612,237 across 6 Drug Manufacturers - General names. LLY ranks #1 (27.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	822	$985,931
2	ABBV	AbbVie Inc.	3,461	$870,926
3	JNJ	Johnson & Johnson	2,878	$730,925
4	MRK	Merck & Co., Inc.	3,033	$389,740
5	AZN	Astrazeneca PLC	1,753	$332,403
6	NVS	Novartis AG	1,929	$302,312

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$985,931	822	-3.6%	Shares	Sole	2026-08-11
2026-03-31	$784,563	853	-0.5%	Shares	Sole	2026-05-14
2025-12-31	$921,000	857	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.